Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Dev Biol ; 384(1): 53-64, 2013 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-24080510

RESUMO

Development and plasticity of synapses are brought about by a complex interplay between various signaling pathways. Typically, either changing the number of synapses or strengthening an existing synapse can lead to changes during synaptic plasticity. Altering the machinery that governs the exocytosis of synaptic vesicles, which primarily fuse at specialized structures known as active zones on the presynaptic terminal, brings about these changes. Although signaling pathways that regulate the synaptic plasticity from the postsynaptic compartments are well defined, the pathways that control these changes presynaptically are poorly described. In a genetic screen for synapse development in Drosophila, we found that mutations in CK2α lead to an increase in the levels of Bruchpilot (BRP), a scaffolding protein associated with the active zones. Using a combination of genetic and biochemical approaches, we found that the increase in BRP in CK2α mutants is largely due to an increase in the transcription of BRP. Interestingly, the transcripts of other active zone proteins that are important for function of active zones were also increased, while the transcripts from some other synaptic proteins were unchanged. Thus, our data suggest that CK2α might be important in regulating synaptic plasticity by modulating the transcription of BRP. Hence, we propose that CK2α is a novel regulator of the active zone protein, BRP, in Drosophila.


Assuntos
Caseína Quinase II/genética , Proteínas de Drosophila/genética , Drosophila/genética , Transcrição Gênica , Animais , Axônios/metabolismo , Drosophila/embriologia , Drosophila/metabolismo , Proteínas de Drosophila/metabolismo , Mutação , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , Vesículas Sinápticas/metabolismo
2.
Virology ; 370(1): 33-44, 2008 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-17904180

RESUMO

In this study we report the development and optimization of two minigenome rescue systems for Nipah virus, a member of the Paramyxoviridae family. One is mediated by the T7 RNA polymerase supplied either by a constitutively expressing cell line or by transfection of expression plasmids and is thus independent from infection with a helper virus. The other approach is based on RNA polymerase I-driven transcription, a unique approach for paramyxovirus reverse genetics technology. Minigenome rescue was evaluated by reporter gene activities of (i) the two different minigenome transcription systems, (ii) genomic versus antigenomic-oriented minigenomes, (iii) different ratios of the viral protein expression plasmids, and (iv) time course experiments. The high efficiency and reliability of the established systems allowed for downscaling to 96-well plates. This served as a basis for the development of a high-throughput screening system for potential antivirals that target replication and transcription of Nipah virus without the need of high bio-containment. Using this system we were able to identify two compounds that reduced minigenome activity.


Assuntos
RNA Polimerases Dirigidas por DNA/metabolismo , Genoma Viral/genética , Vírus Nipah/fisiologia , Plasmídeos/genética , RNA Polimerase I/metabolismo , RNA Viral/metabolismo , Proteínas Virais/metabolismo , Antivirais/farmacologia , Linhagem Celular , Cloranfenicol O-Acetiltransferase/metabolismo , RNA Polimerases Dirigidas por DNA/genética , Células HeLa , Humanos , Testes de Sensibilidade Microbiana/métodos , Vírus Nipah/efeitos dos fármacos , Vírus Nipah/genética , Paramyxoviridae/genética , Paramyxoviridae/metabolismo , RNA Polimerase I/genética , RNA Viral/efeitos dos fármacos , RNA Viral/genética , Transcrição Gênica/efeitos dos fármacos , Transfecção , Proteínas Virais/genética , Replicação Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA